Latest News and Press Releases
Want to stay updated on the latest news?
-
Unnatural Products Announces Multi-Target Collaboration with argenx to Develop Oral Macrocyclic Peptide Therapeutics
-
Unnatural Products Appoints Abbas Kazimi and Mert Aktar to Board of Directors
-
Unnatural Products Announces BridgeBio Exercises Option to License Macrocyclic Therapeutics for Development in Rare Diseases and Oncology
-
Unnatural Products Appoints Simon Bailey, Ph.D., as Chief Operating Officer and President of R&D